Establishment of transgenic fibroblasts for producing recombinant human interferon-α and erythropoietin in bovine milk

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 406-412

  Jung, Eui Man ^a   An, Beum Soo ^a   Kim, Yu Kyung ^b   Hwang, Inho ^a   Lee, Jong Yun ^b   Shin, Tae Young ^b   Hyun, Sang Hwan ^a   Hwang, Woo Suk ^b   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

^b Sooam Biotech Research Foundation   (South Korea)

Author keywords

Cow; EPO; Fibroblast; IFN ; Milk protein gene promoter

Indexed keywords

ALPHA INTERFERON; CASEIN; ERYTHROPOIETIN; GENOMIC DNA; HUMAN INTERFERON; MILK PROTEIN;

ANIMAL CELL; ARTICLE; DNA EXTRACTION; DNA VECTOR; EPITHELIUM CELL; FIBROBLAST; GENETIC TRANSFECTION; LACTATION; MILK; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN SYNTHESIS; SOMATIC CELL; TRANSGENIC CATTLE; TRANSGENIC FIBROBLAST;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CASEINS; CATTLE; CELLS, CULTURED; ERYTHROPOIETIN; FEMALE; FIBROBLASTS; GENETIC VECTORS; HUMANS; INTERFERON-ALPHA; MAMMARY GLANDS, ANIMAL; MICE; MILK; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS;

EID: 84873285192     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1182     Document Type: Article

References (54)

1. Fleischmann WR Jr, Kleyn KM and Baron S: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst 65: 963-966, 1980.
2. Randall RE and Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47, 2008.
3. Baron S, Hernandez J, Bekisz J, et al: Clinical model: interferons activate human monocytes to an eradicative tumor cell level in vitro. J Interferon Cytokine Res 27: 157-163, 2007.
4. Liu YJ: IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306, 2005.
5. Schoenborn JR and Wilson CB: Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96: 41-101, 2007.
6. Cantell K and Hirvonen S: Large-scale production of human leukocyte interferon containing 10(8) units per ml. J Gen Virol 39: 541-543, 1978.
7. Cantell K and Hirvonen S: Preparation of human leukocyte interferon for clinical use. Tex Rep Biol Med 35: 138-144, 1977.
8. Radaeva S, Jaruga B, Hong F, et al: Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122: 1020-1034, 2002.
9. Wang CJ, Xiao CW, You TG, et al: Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma. Mol Cancer 11: 31, 2012.
10. Jelkmann W: Erythropoietin: structure, control of production and function. Physiol Rev 72: 449-489, 1992.
11. Lacombe C, Da Silva JL, Bruneval P, et al: Identification of tissues and cells producing erythropoietin in the anemic mouse. Contrib Nephrol 66: 17-24, 1988.
12. Neumann E: Regulation of erythropoiesis. Acta Med Austriaca Suppl 6: 360-363, 1979 (In German).
13. Argenti M: Hematosis and erythropoiesis in guinea pigs exposed to low oxygen pressure. Riv Med Aeronaut 14: 283-313, 1951 (In Italian).
14. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W and Koch KM: Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 54: 877-884, 1979.
15. Fisher JW: Mechanism of the anemia of chronic renal failure. Nephron 25: 106-111, 1980.
16. McGonigle RJ, Wallin JD, Shadduck RK and Fisher JW: Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 25: 437-444, 1984.
17. Baneyx F: Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 10: 411-421, 1999.
18. Houdebine LM: Transgenic animal bioreactors. Transgenic Res 9: 305-320, 2000.
19. Lubo H and Palmer C: Transgenic animal bioreactors - where we are. Transgenic Res 9: 301-304, 2000.
20. Bühler TA, Bruyère T, Went DF, Stranzinger G and Burki K: Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Biotechnology (NY) 8: 140-143, 1990.
21. Cerdan MG, Young JI, Zino E, et al: Accurate spatial and temporal transgene expression driven by a 3. 8-kilobase promoter of the bovine beta-casein gene in the lactating mouse mammary gland. Mol Reprod Dev 49: 236-245, 1998.
22. Ebert KM, Di Tullio P, Barry CA, et al: Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Biotechnology (NY) 12: 699-702, 1994.
23. Gordon K, Lee E, Vitale JA, Smith AE, Westphal H and Hennighausen L: Production of human tissue plasminogen activator in transgenic mouse milk. 1987. Biotechnology 24: 425-428, 1992.
24. Ikonen T, Ojala M and Ruottinen O: Associations between milk protein polymorphism and first lactation milk production traits in Finnish Ayrshire cows. J Dairy Sci 82: 1026-1033, 1999.
25. Hennighausen LG, Sippel AE, Hobbs AA and Rosen JM: Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res 10: 3733-3744, 1982.
26. Malewski T and Zwierzchowski L: Computer-aided analysis of potential transcription-factor binding sites in the rabbit beta-casein gene promoter. Biosystems 36: 109-119, 1995.
27. Rosen JM, Wyszomierski SL and Hadsell D: Regulation of milk protein gene expression. Annu Rev Nutr 19: 407-436, 1999.
28. Raught B, Liao WS and Rosen JM: Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol 9: 1223-1232, 1995.
29. Buser AC, Gass-Handel EK, Wyszomierski SL, et al: Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol 21: 106-125, 2007.
30. Doppler W, Windegger M, Soratroi C, et al: Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5. Mol Cell Biol 21: 3266-3279, 2001.
31. Zinovieva N, Lassnig C, Schams D, et al: Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations. Transgenic Res 7: 437-447, 1998.
32. Coulibaly S, Besenfelder U, Fleischmann M, et al: Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits. FEBS Lett 444: 111-116, 1999.
33. Devinoy E, Thépot D, Stinnakre MG, et al: High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland. Transgenic Res 3: 79-89, 1994.
34. Cheng CK, Hoo RL, Chow BK and Leung PC: Functional cooperation between multiple regulatory elements in the untranslated exon 1 stimulates the basal transcription of the human GnRH-II gene. Mol Endocrinol 17: 1175-1191, 2003.
35. Lee GS, Choi KC, Han HJ and Jeung EB: The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol Cell Endocrinol 277: 42-50, 2007.
36. Song S and Oka T: Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium. Am J Physiol Endocrinol Metab 284: E1119-E1124, 2003.
37. Jung EM, Kim YK, Lee GS, Hyun SH, Hwang WS and Jeung EB: Establishment of inducible cAMP early repressor transgenic fibroblasts in a porcine model of human type 1 diabetes mellitus. Mol Med Report 6: 239-245, 2012.
38. Kim YK, Lee GS, Jung EM, Hyun SH, Hwang WS and Jeung EB: Generation of fibroblasts overexpressing liver-specific PEPCK in a miniature pig model of human type 2 diabetes mellitus. Mol Med Report 6: 45-50, 2012.
39. Houdebine LM: Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 32: 107-121, 2009.
40. Hodges CA and Stice SL: Generation of bovine transgenics using somatic cell nuclear transfer. Reprod Biol Endocrinol 1: 81, 2003.
41. Riego E, Limonta J, Aguilar A, et al: Production of transgenic mice and rabbits that carry and express the human tissue plasminogen activator cDNA under the control of a bovine alpha S1 casein promoter. Theriogenology 39: 1173-1185, 1993.
42. Kuss AW, Gogol J, Bartenschlager H and Geldermann H: Polymorphic AP-1 binding site in bovine CSN1S1 shows quantitative differences in protein binding associated with milk protein expression. J Dairy Sci 88: 2246-2252, 2005.
43. Chessa S, Chiatti F, Ceriotti G, et al: Development of a single nucleotide polymorphism genotyping microarray platform for the identification of bovine milk protein genetic polymorphisms. J Dairy Sci 90: 451-464, 2007.
44. Houdebine LM, Teyssot B, Djiane J and Devinoy E: Control of the expression of milk protein genes by prolactin, glucocorticoids and progesterone. Ann Endocrinol (Paris) 43: 354-369, 1982 (In French).
45. Pierre S, Jolivet G, Devinoy E, et al: A distal region enhances the prolactin induced promoter activity of the rabbit alpha s1-casein gene. Mol Cell Endocrinol 87: 147-156, 1992.
46. Shingo T, Gregg C, Enwere E, et al: Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 299: 117-120, 2003.
47. Kamel MA, Neulen J, Sayed GH, Salem HT and Breckwoldt M: Heterogeneity of human prolactin levels in serum during the early postpartum period. Gynecol Endocrinol 7: 173-177, 1993.
48. Orru MG, Baita A, Sitzia R, et al: Interferon-alpha-induced psychiatric side effects in patients with chronic viral hepatitis: a prospective, observational, controlled study. Epidemiol Psichiatr Soc 14: 145-153, 2005 (In Italian).
49. Ferrantini M, Capone I and Belardelli F: Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89: 884-893, 2007.
50. Oster W, Herrmann F, Gamm H, et al: Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 8: 956-962, 1990.
51. Son YD, Jeong YT, Park SY and Kim JH: Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. Glycobiology 21: 1019-1028, 2011.
52. Tuite MF, Dobson MJ, Roberts NA, et al: Regulated high efficiency expression of human interferon-alpha in Saccharomyces cerevisiae. EMBO J 1: 603-608, 1982.
53. Wall RJ, Kerr DE and Bondioli KR: Transgenic dairy cattle: genetic engineering on a large scale. J Dairy Sci 80: 2213-2224, 1997.
54. Zuelke KA: Transgenic modification of cows milk for value-added processing. Reprod Fertil Dev 10: 671-676, 1998.